Clinical Trial Update: Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 presurgical study in primary breast cancer evaluating molecular predictors of lapatinib's effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tykerb (lapatinib)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED